RT Journal Article
SR Electronic
T1 Steroid-responsive encephalitis in Covid-19 disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.12.20062646
DO 10.1101/2020.04.12.20062646
A1 Andrea Pilotto
A1 Silvia Odolini
A1 Stefano Masciocchi S
A1 Agnese Comelli
A1 Irene Volonghi
A1 Stefano Gazzina
A1 Sara Nocivelli
A1 Alessandro Pezzini
A1 Emanuele Focà
A1 Arnaldo Caruso
A1 Matilde Leonardi
A1 Maria Pia Pasolini
A1 Roberto Gasparotti R
A1 Francesco Castelli F
A1 Nicholas J. Ashton
A1 Kaj Blennow
A1 Henrik Zetterberg
A1 Alessandro Padovani
YR 2020
UL http://medrxiv.org/content/early/2020/05/14/2020.04.12.20062646.abstract
AB Covid-19 infection has the potential for targeting the central nervous system and several neurological symptoms have been described in patients with severe respiratory distress. Here we described the case of a 60-year old subject with SARS-CoV-2 infection but only mild respiratory abnormalities who developed an akinetic mutism due to encephalitis. MRI was negative whereas EEG showed generalized theta slowing. CSF analyses during the acute stage were negative for SARS-CoV-2, positive for pleocytosis and hyperproteinorrachia, and showed increased IL-8 and TNF-α concentrations while other infectious or autoimmune disorders were excluded. A progressive clinical improvement along with a reduction of CSF parameters was observed after high-dose steroid treatment, thus arguing for an inflammatory-mediated brain involvement related to Covid-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was not financially supported.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available upon responsible request by contacting the corresponding author